ArticleBioinformation2026
Seroprevalence and HBeAg status of hepatitis B virus infection among pregnant women.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatitis B virus (HBV) infection during pregnancy significantly risks mother-to-child transmission, particularly among HBeAg-positive mothers requiring routine antenatal screening. This hospital-based cross-sectional study assessed HBsAg and HBeAg seroprevalence among pregnant women attending an antenatal clinic from January to December 2023. Serum samples underwent ELISA testing for HBsAg, with HBeAg evaluation for all positive cases, revealing overall HBsAg seroprevalence of 2.0%. Among HBsAg-positive women, 33.3% demonstrated HBeAg positivity, identifying high-risk cases for perinatal transmission. These findings advance maternal health protocols by confirming the necessity of targeted antenatal screening and preventive strategies to minimize HBV vertical transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.